ArticleNeurology and therapy2024

The Clinical Development of Taldefgrobep Alfa: An Anti-Myostatin Adnectin for the Treatment of Duchenne Muscular Dystrophy.

Francesco Muntoni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.